admin Share This! FacebookTwitterPinterestLinkedIn Investing News Syringe Maker Catalent Anticipates Boost From Demand for Injectable Weight-Loss Drugs November 15, 202383 Views1 Min Read Syringe maker Catalent said it expects to benefit from soaring demand for injectable weight-loss drugs, and shares surged. You may also like Investing News The Dow Broke a Half-Century-Old Record—Here’s What It could Mean for Your Money in 2025 1 hour ago Investing News Measuring Company Efficiency To Maximize Profits 1 hour ago Investing News Warren Buffett’s Berkshire Hathaway scoops up Occidental and other stocks during sell-off 3 hours ago Ackman’s Pershing Square Nearly Doubles Stake in Alphabet’s Class A Shares Wells Fargo Savings Account Interest Rates: November 2023 Share This! FacebookTwitterPinterestLinkedIn Newsletter NavigationInvesting News Market Insider Stock Market Stocks to buy Stocks to sell Dividend Stocks Trader Talk Videos Privacy Policy DMCA / Copyrights Disclaimer Terms and Conditions Disclaimer Whitelist Us
Investing News The Dow Broke a Half-Century-Old Record—Here’s What It could Mean for Your Money in 2025 1 hour ago
Investing News Warren Buffett’s Berkshire Hathaway scoops up Occidental and other stocks during sell-off 3 hours ago